Flow cytometry has become a highly valuable method to monitor minimal residual disease (MRD)
and evaluate the depth of complete response (CR) in bone marrow (BM) of multiple …

Introduction and objectives The cardiac sequelae of SARS-CoV-2 infection are still poorly
documented. We conducted a cross-sectional study in healthcare workers to report evidence …

In recent years the volume and complexity of flow cytometry data has increased substantially.
This has led to a greater number of identifiable cell populations in a single measurement. …

The rise in the analytical speed of mutiparameter flow cytometers made possible by the
introduction of digital instruments, has brought up the possibility to manage progressively higher …

Precise classification of acute leukemia (AL) is crucial for adequate treatment. EuroFlow has
previously designed an AL orientation tube (ALOT) to guide toward the relevant …

Background Multiparameter flow cytometry (FC) immunophenotyping is a key tool for
detailed identification and characterization of human blood leucocytes, including B-lymphocytes …

Low‐count monoclonal B‐cell lymphocytosis (MBL lo ) has been associated with an underlying
immunodeficiency and has recently emerged as a new risk factor for severe COVID‐19. …

Reproducible expert-independent flow-cytometric criteria for the differential diagnoses between
mature B-cell neoplasms are lacking. We developed an algorithm-driven classification …

Background Systemic mastocytosis (SM) is a heterogeneous disease characterized by an
expansion of KIT-mutated mast cells (MC). KIT-mutated MC display activated features and …

Conflict of interest: COI declared-see note COI notes: A. Orfao and J. Almeida report being
one of the inventors on the EuroFlow-owned European patent 119646NL00 registered on …